Minglu Zhou
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoplatforms for cancer theranostics 13
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Yuan Huang (19 shared papers)Xi Lin (5 shared papers)Zhou Zhou (6 shared papers)Lian Li (4 shared papers)Qiuyi Li (3 shared papers)Qiuyi Li (5 shared papers)Lian Li (2 shared papers)Lijia Li (1 shared paper)
- Journals
- Acta Pharmaceutica Sinica B (2 papers)Advanced Science (2 papers)International Journal of Pharmaceutics (2 papers)Nano Research (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Minglu Zhou
29 papers receiving 631 citations
Peers
Comparison fields: 5 of 70
- Biomaterials 165
- Pharmaceutical Science 52
- Cancer Research 89
- Biomedical Engineering 260
- Immunology 82
Countries citing papers authored by Minglu Zhou
This map shows the geographic impact of Minglu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minglu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minglu Zhou more than expected).
Fields of papers citing papers by Minglu Zhou
This network shows the impact of papers produced by Minglu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minglu Zhou. The network helps show where Minglu Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Minglu Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 79 | |
| 2 | 2018 | 58 | |
| 3 | 2020 | 48 | |
| 4 | 2020 | 43 | |
| 5 | 2019 | 42 | |
| 6 | 2022 | 39 | |
| 7 | 2021 | 37 | |
| 8 | 2019 | 35 | |
| 9 | 2022 | 32 | |
| 10 | 2017 | 26 | |
| 11 | 2024 | 20 | |
| 12 | 2015 | 20 | |
| 13 | 2024 | 17 | |
| 14 | 2021 | 16 | |
| 15 | 2021 | 16 | |
| 16 | 2021 | 14 | |
| 17 | 2021 | 12 | |
| 18 | 2020 | 11 | |
| 19 | 2021 | 11 | |
| 20 | 2017 | 11 |
About Minglu Zhou
Minglu Zhou is a scholar working on Biomedical Engineering, Molecular Biology, Oncology, Biomaterials and Immunology, having authored 29 papers that have together received 636 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (7 papers), Conducting polymers and applications (4 papers), Immunotherapy and Immune Responses (4 papers), Organic Electronics and Photovoltaics (3 papers), Glycosylation and Glycoproteins Research (2 papers), Organic Light-Emitting Diodes Research (2 papers) and Photodynamic Therapy Research Studies (2 papers). The work is most often cited by research in Biomaterials (165 citations), Pharmaceutical Science (52 citations), Cancer Research (89 citations), Biomedical Engineering (260 citations) and Immunology (82 citations). Minglu Zhou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yuan Huang, Xi Lin, Zhou Zhou, Lian Li, Qiuyi Li, Qiuyi Li, Lian Li, Lijia Li, Fengling Wang and Dandan Xie. Their work appears in journals such as Acta Pharmaceutica Sinica B, Advanced Science, International Journal of Pharmaceutics, Nano Research and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.